Mirabegron
Top View
- Mirabegron: Hypertension, the Extrapyramidal Reactions Reported of Treatment in 22 Cases
- 213006Orig1s000
- Washington Preferred Drug List
- Betmiga, INN-Mirabegron
- Concentration-Dependent Alpha1-Adrenoceptor Antagonism and Inhibition of Neurogenic Smooth Muscle Contraction by Mirabegron in the Human Prostate
- 90-Day Extended Supply Medications (PDF)
- Wirral Guidelines for Pharmacological Management of Overactive Bladder Syndrome (OAB) in Adults in Primary and Secondary Care
- Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
- Pharmacological Management of Overactive Bladder (OAB) Syndrome in Primary Care
- Betmiga, INN-Mirabegron
- PDL)/Non-Preferred Drug List (NPDL
- Adrenoreceptor Blocker in Patients with Benign Prostatic Hyperplasia with Persistent Overactive Bladder Symptoms: a Prospective Study
- Oral Medicines for the Management of Urinary Incontinence, Frequency & Overactive Bladder
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- Supplemental Table 1. List of Substances and Markers Tested by Definitive Urine Drug Test and DDI Test
- The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: Results of a US Consensus Panel of Experts
- Creativity Assessment in Subjects with Tourette Syndrome Vs. Patients with Parkinson’S Disease: a Preliminary Study
- Overactive Bladder Agents Criteria